Could a hot flash pill also protect your heart?
NCT ID NCT07077395
Summary
This study is testing whether a new drug called elinzanetant, designed to treat moderate-to-severe hot flashes, can also improve the health of blood vessels in menopausal women. It will involve 80 women aged 40-65 who have hot flashes and certain risk factors for heart and metabolic problems. Researchers will measure how well the participants' blood vessels expand and look for changes in blood markers related to inflammation and blood vessel health.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MENOPAUSE-RELATED HOT FLASHES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.